Pliant Therapeutics (PLRX) Other financing activities (2020 - 2023)
Pliant Therapeutics (PLRX) posted quarterly Other financing activities of $270.3 million for Q1 2023, up 25.0% quarter-over-quarter from $216.2 million in Q3 2022.
Pliant Therapeutics (PLRX) Other financing activities (2020 - 2023) Analysis & Trends
Pliant Therapeutics (PLRX) has reported Other financing activities for 4 consecutive years, with $270.3 million the latest figure, recorded in Q1 2023.
- In Q1 2023, Other financing activities changed N/A year-over-year to $270.3 million; the TTM figure through Dec 2023 stood at $270.3 million (up 25.0% YoY), while the FY2023 annual figure was $270.3 million, up 25.0% from the prior year.
- Other financing activities climbed to $270.3 million in Q1 2023 per PLRX's latest filing, from $216.2 million in the prior quarter.
- Across five years, Other financing activities topped out at $270.3 million in Q1 2023 and bottomed at -$150.3 million in Q4 2020.
- Historically, Other financing activities has averaged $54.1 million across 4 years, with a median of $1.4 million in 2021.
- Annual changes were most pronounced in 2021 — Other financing activities slumped 101.24% — and 2022, when it soared 12518.21%.
- Pliant Therapeutics' Other financing activities stood at -$150.3 million in 2020, then soared by 98.84% to -$1.7 million in 2021, then jumped by 12518.21% to $216.2 million in 2022, then advanced by 25.0% to $270.3 million in 2023.
- Business Quant data shows PLRX's Other financing activities at $270.3 million in Q1 2023, $216.2 million in Q3 2022, and -$1.7 million in Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Pliant Therapeutics | 70.59 Mn | 70.59 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 270.25 Mn |
| Mar 31, 2023 | 270.25 Mn |
| Sep 30, 2022 | 216.20 Mn |
| Sep 30, 2022 | 216.20 Mn |
| Sep 30, 2021 | -1.74 Mn |
| Sep 30, 2021 | -1.74 Mn |
| Jun 30, 2021 | 371,000.00 |
| Jun 30, 2021 | 371,000.00 |
| Mar 31, 2021 | 1.37 Mn |
| Mar 31, 2021 | 1.37 Mn |
| Dec 31, 2020 | -150.31 Mn |
| Dec 31, 2020 | -150.31 Mn |
| Sep 30, 2020 | 140.75 Mn |
| Sep 30, 2020 | 140.75 Mn |
| Jun 30, 2020 | 9.97 Mn |
| Jun 30, 2020 | 9.97 Mn |
| Mar 31, 2020 | 26,000.00 |
| Mar 31, 2020 | 26,000.00 |